Truncated chromatin open element sequences, their combinations and applications
Truncated UCOE sequences integrated with PiggyBac transposon systems address inefficiencies in cell line construction by improving transfection efficiency and stability, shortening the construction cycle, and maintaining high yield for antibody production.
Patent Information
- Application Number
- TW114139082
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-10
- Filing Date
- 2025-10-09
- Publication Date
- 2026-08-01
AI Technical Summary
Current methods for constructing stable cell lines for antibody production face low integration efficiency, labor-intensive screening, poor target gene stability, and slow cell line construction times, particularly when using unopened chromatin elements (UCOEs) in CHO cells, with issues like low transfection efficiency and long construction cycles.
Integration of truncated chromatin open elements (UCOEs) with PiggyBac transposon systems, utilizing specific ITR sequences for precise genome insertion, enabling rapid bulkpool screening and significantly shortening construction cycles while maintaining high protein yield.
The combined use of truncated UCOE sequences with ITRs enhances transfection efficiency, stabilizes target gene expression, and accelerates cell line development by 4-5 weeks, facilitating rapid industrial-scale antibody production.